Dongwha Pharm.Co.Ltd (000020) — Cash Flow-to-Debt Ratio
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of ₩697.02 Million could theoretically repay 0% of its total liabilities (₩238.27 Billion) in one year. Explore Dongwha Pharm.Co.Ltd (000020) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dongwha Pharm.Co.Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Dongwha Pharm.Co.Ltd across 15 annual periods. Also explore balance sheet size of Dongwha Pharm.Co.Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year debt coverage analysis for Dongwha Pharm.Co.Ltd. For market capitalisation and broader financial context, see Dongwha Pharm.Co.Ltd (000020) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩15.70 Billion | ₩240.73 Billion | ▲ +455.1% |
| 2024 | -0.02x | ₩-4.00 Billion | ₩217.96 Billion | ▼ -109.9% |
| 2023 | 0.18x | ₩29.17 Billion | ₩157.92 Billion | ▼ -47.9% |
| 2022 | 0.35x | ₩29.22 Billion | ₩82.46 Billion | ▼ -13.8% |
| 2021 | 0.41x | ₩36.03 Billion | ₩87.67 Billion | ▼ -28.3% |
| 2020 | 0.57x | ₩52.23 Billion | ₩91.13 Billion | ▲ +224.2% |
| 2019 | 0.18x | ₩13.28 Billion | ₩75.15 Billion | ▲ +396.8% |
| 2018 | -0.06x | ₩-4.36 Billion | ₩73.20 Billion | ▲ +74.7% |
| 2017 | -0.24x | ₩-16.52 Billion | ₩70.28 Billion | ▼ -166.1% |
| 2016 | 0.36x | ₩25.48 Billion | ₩71.68 Billion | ▲ +56.1% |
| 2015 | 0.23x | ₩19.83 Billion | ₩87.07 Billion | ▲ +40.5% |
| 2014 | 0.16x | ₩13.51 Billion | ₩83.35 Billion | ▲ +75.8% |
| 2013 | 0.09x | ₩8.21 Billion | ₩88.93 Billion | ▼ -64.4% |
| 2012 | 0.26x | ₩25.23 Billion | ₩97.29 Billion | ▼ -38.4% |
| 2011 | 0.42x | ₩46.24 Billion | ₩109.81 Billion | — |